Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GDA | Q9Y2T3 | 2/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TYMP | P19971 | 5/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | IDH1 | O75874 | 1/20 | 0.39 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uric Acid SCHEMBL924097 | 0.97 | GDA (0.89) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL3417988 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL22069923 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL7933 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL1331321 | 0.97 | GDA (1.00) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL11473111 | 0.95 | GDA (0.84) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL2434620 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL16213309 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL196769 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD | |
| Uric Acid SCHEMBL1071965 | 0.94 | GDA (0.94) | GDAALDH1A1CYP1A2CYP2C9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5171 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119791058-B | Pain rheumatism heat syndrome subtype modeling method, biomarker group application and detection method | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2026-05-19 | — | — | CN | claimed |
| CN-118370268-B | Construction method of uric acid crystallization kidney injury animal model | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2026-05-12 | — | — | CN | claimed |
| US-12566174-B2 | Method and kit for determining the presence of monosodium urate crystals in joint synovial fluid | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-03-03 | — | — | US | claimed |
| CN-121582139-A | Target symptom identification method, device, equipment and medium based on dual-energy CT | 国科离子医疗科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-12324799-B2 | Methods and uses of colchicine derivatives | ALBERTA HEALTH SERVICES (CA) | 2025-06-10 | — | — | US | claimed |
| CN-119804581-A | Quality control liquid and application thereof | 艾康生物技术(杭州)有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119791058-A | Pain rheumatism heat syndrome subtype modeling method, biomarker group application and detection method | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2025-04-11 | — | — | CN | claimed |
| CN-118111933-B | Equipment for evaluating gout attack risk based on monosodium urate crystal growth rate | 南方医科大学南方医院 | 2025-04-04 | — | — | CN | claimed |
| EP-4528273-A1 | QUALITY CONTROL SOLUTION AND USE THEREOF | Leadway (HK) Limited (CN) | 2025-03-26 | — | — | EP | claimed |
| WO-2025037010-A1 | FUSED PIPERIDINYL BICYCLIC AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES | INFLARX GMBH (DE) | 2025-02-20 | — | — | WO | claimed |
| US-6544726-B1 | Mixture for organ preservation | VAN DYKE KNOX (US) | 2003-04-08 | — | — | US | claimed |
| US-20030040036-A1 | Synovial fluid control | QUANTIMETRIX CORPORATION | 2003-02-27 | — | — | US | claimed |
| US-20020132758-A1 | Method for identifying compounds to treat medical pathologies associated with molecular crystallization | SHELL JOHN W (US) | 2002-09-19 | — | — | US | claimed |
| WO-2002057796-A2 | COMPOUNDS FOR TREATING PATHOLOGIES ASSOCIATED WITH MOLECULAR CRYSTALLIZATION | SHELL JOHN W (US) | 2002-07-25 | — | — | WO | claimed |
| WO-2002000933-A2 | SCREENING ASSAYS FOR IDENTIFYING MODULATORS OF THE INFLAMMATORY OR IMMUNE RESPONSES | INTERLEUKIN GENETICS, INC. (US) | 2002-01-03 | — | — | WO | claimed |
| EP-1159941-A2 | Formulations for use in enzyme-orthokeratology | Ista Pharmaceuticals, Inc. (US) | 2001-12-05 | — | — | EP | claimed |
| CN-1279275-A | Disinfecting washing powder and its preparing process | MINGFENG DAILY CHEMICALS CO LT (CN) | 2001-01-10 | — | — | CN | claimed |
| CN-1258448-A | Hand disinfectant for preoperation use and personal hygiene and its preparation | TIANJIN AIHUA FRESHENER CO LTD (CN) | 2000-07-05 | — | — | CN | claimed |
| US-5648228-A | Measuring activity toward production of activated blood coagulation factor XII, plasma kallikrein or bradykinin using reconstituted kallikrein-kinin system | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1997-07-15 | — | — | US | claimed |
| US-5599683-A | Method for measuring production activity of test substance towards FXIIa | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 1997-02-04 | — | — | US | claimed |